A genetic risk factor could explain why some people lose their senses of smell and taste when they get infected with COVID-19, according to a new study.
/webmd/consumer_assets/site_images/article_thumbnails/video/1800x1200_krames_activating_health_how_mrna_vaccine_works_video.jpgResearchers at 23andMe, a genomics and biotechnology company, did the study as part of a larger COVID-19 project, which includes people in the U.S. and the U.K. They analyzed data from nearly 70,000 people who took online surveys after receiving a positive coronavirus test. Among those, 68% reported a loss of smell or taste as a symptom.and taste and those who didn’t.
The research team also found that women were 11% more likely than men to report a loss of smell and taste. About 73% of those who reported a loss of smell and taste were ages 26-35. The researchers aren’t sure how the genes are involved, though they suspect that infected cells could lead to smell loss. Typically, the genes are expressed in tissue inside the nose involved with smell and play a role in processing things that have an odor. To use the findings, researchers need to learn more about the genes, how they are expressed, and what their functions are, NBC News reported.
The findings could help lead to treatments. Other research has shown that the loss of taste and smell is related to a “failure to protect the sensory cells of the nose and
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Northwestern Medicine Study Gives Clues About How Long COVID-19 Symptoms Can LingerA new study from Northwestern Medicine gives more clues about just how long COVID-19 symptoms can linger.
Baca lebih lajut »
Northwestern Medicine Study Gives Clues About How Long COVID-19 Symptoms Can LingerA new study from Northwestern Medicine gives more clues about just how long COVID-19 symptoms can linger.
Baca lebih lajut »
FDA acts to expand use of treatment for COVID-19 patients with mild-to-moderate diseasePreviously, the use of Veklury, a Gilead Sciences Inc. drug, was limited to those requiring hospitalization.
Baca lebih lajut »
Southlake’s COVID-19 cases on the rise with 5,554 confirmed casesSince the outbreak of the coronavirus, Southlake has recorded a total of 5,310 confirmed cases, an increase of 352 cases over the past week, according to...
Baca lebih lajut »
'Mission: Impossible' Sequels Postponed Another Year Due to Covid-19The upcoming 'Mission: Impossible' sequels have postponed their release dates nearly a year due to the Covid-19 pandemic
Baca lebih lajut »